The FDA has previously sent warning letters to compounders promoting peptides including BPC-157, TB-500, and related research compounds as therapeutic agents, signaling regulatory scrutiny of the broader peptide compounding space [13]
In particular, researchers have measured the peptides effect on LDL/HDL ratios, triglyceride levels, and arterial stiffness
Speculative timelines should not be applied to unlicensed products
Always Consult a Professional While AOD 9604 therapy may have a number of promising applications in areas such as fat loss, metabolic health, and joint support, it is important to recognize that peptide treatments are not a universal remedy
Login Cart (0) Shopping Cart: 0 Items Your shopping cart is currently empty
Start at the low end of the beginner tier and extend the observation period to three weeks instead of two before increasing